Latest News from: Roswell Park Comprehensive Cancer Center

Add to Favorites Subscribe Share
Go to Advanced Search

Showing results

110 of 302
Drs.MaciejGoniewiczandRichardOConnor_Image2_SmallerSize.jpg

Article ID: 700896

Roswell Park and URMC To Create $19 Million Research Program Focused on Flavored Tobacco

Roswell Park Comprehensive Cancer Center

The expertise of two regional research teams has earned a federal grant of nearly $20 million to create the nation’s first program dedicated to the study of flavored tobacco.

Released:
21-Sep-2018 7:40 AM EDT
ErnstoffMarcOctober042017.jpg

Article ID: 700453

New Immunotherapy Approach Found in “Superagonist” Interleukin-15 Complex

Roswell Park Comprehensive Cancer Center

A team led by Marc Ernstoff, MD, of Roswell Park Comprehensive Cancer Center found that a drug complex containing IL-15 is both safe and well tolerated in patients with advanced solid tumors.

Released:
12-Sep-2018 6:05 PM EDT
MaciejGoniewiczinTobaccoResearchLaboratory.jpg

Article ID: 700184

Adolescent Users of Juul, Other E-Cigarette Pods Exposed to Nearly As Much Nicotine as Smokers, Study Shows

Roswell Park Comprehensive Cancer Center

A new Roswell Park/Stony Brook Children's Hospital study reports striking findings: that young users of newer “pod” e-cigarette devices are absorbing nicotine at levels approaching nicotine exposure from traditional combustible cigarettes.

Released:
7-Sep-2018 9:45 AM EDT
TangDean-environmental.jpg

Article ID: 700078

Roswell Park Team Identifies Possible Cause of Resistance to Prostate Cancer Treatment

Roswell Park Comprehensive Cancer Center

A Roswell Park-led research team has linked the development of castration-resistant prostate cancer and resistance to treatment to a lack of androgen receptor expression in prostate cancer cells, identifying a new therapeutic target. Their findings were published in the journal Nature Communications.

Released:
6-Sep-2018 8:05 AM EDT
ImageforDr.KauffmansResearch.jpg

Article ID: 699657

Roswell Park Approach to Assessing Kidney Tumors May Spare Some Patients Surgery

Roswell Park Comprehensive Cancer Center

A research team from Roswell Park Comprehensive Cancer Center has discovered a way to use computed tomography (CT) imaging to assess kidney tumors that test positive for the biomarker CD117 and accurately determine — before surgery — whether the tumor is benign or malignant.

Released:
28-Aug-2018 2:20 PM EDT
buffalo_healthcare_exploration_smaller_image.jpg

Article ID: 698973

Local High School Students Explore Diverse Healthcare Field at Roswell Park

Roswell Park Comprehensive Cancer Center

y-two local high school students participated in a unique career development program at Roswell Park Comprehensive Cancer Center this summer. The Buffalo Healthcare Exploration (BHE) program

Released:
14-Aug-2018 1:05 PM EDT

Education

PatrickBolandinClinic.jpg

Article ID: 695500

New Treatment Combination Improves Outcomes for Some Patients with Colorectal Cancer

Roswell Park Comprehensive Cancer Center

Research to be presented at the ASCO 2018 Annual Meeting suggests that a new treatment combination can extend survival for many patients with advanced colorectal cancer and that its efficacy compares favorably to single-agent approaches.

Released:
2-Jun-2018 11:05 AM EDT
AhmedElkhananyandKazuakiTakabeMay3020184.jpg

Article ID: 695498

Differences in Immune Cell Environment Help Explain Racial Disparities in Breast Cancer

Roswell Park Comprehensive Cancer Center

Roswell Park Comprehensive Cancer Center researchers have identified significant differences in the immune microenvironment of breast cancer tumors between African-American and white women, shedding light on the ways in which race can influence cancer development and outcomes. The findings, to be presented at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, are based on based on a comprehensive review of data from The Cancer Genome Atlas.

Released:
1-Jun-2018 6:05 PM EDT
FenstermakerandCiesielskiLab2012-08-2133.jpg

Article ID: 695497

Interim Results from Clinical Trial of Immunotherapy for Glioblastoma Show Significant Clinical Benefit

Roswell Park Comprehensive Cancer Center

Presenting new data at ASCO 2018, collaborators from Roswell Park Comprehensive Cancer Center, the Cleveland Clinic and MimiVax LLC report that the combination of SurVaxM plus standard therapy for patients with glioblastoma appears to be safe, effective and worthy of further evaluation.

Released:
1-Jun-2018 5:05 PM EDT
BuasMatthew.jpg

Article ID: 693056

Roswell Park Researchers Identify Epigenetic Changes that May Help Explain Racial Disparities in Breast Cancer

Roswell Park Comprehensive Cancer Center

Roswell Park Comprehensive Cancer Center researchers have identified epigenetic differences in the breast cancer tumors of African-American women and women of European descent, shedding light on one mechanism by which race may influence the way breast cancer develops.

Released:
18-Apr-2018 11:05 AM EDT

Showing results

110 of 302

Chat now!